# LOTEPREDNOL ETABONATE

NDC: 60219-1362
Generic name: loteprednol etabonate
Labeler / Manufacturer: Amneal Pharmaceuticals NY LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: SUSPENSION/ DROPS
Routes: OPHTHALMIC
Marketing started: 20250522

FDA application: ANDA217484

## Active ingredients

- LOTEPREDNOL ETABONATE: 5 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"60219-1362"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=60219-1362
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e8b50444-fd49-427e-9c1b-f75cb1b62bb6